Dr. Devarajan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3333 Burnet Ave
Ml 7022
Cincinnati, OH 45229Phone+1 513-636-4531Fax+1 513-636-7407
Summary
- Dr. Prasad Devarajan is a pediatric nephrologist in Cincinnati, OH and is affiliated with Cincinnati Children's Hospital Medical Center. He received his medical degree from L. Tilak Municipal Medical College and has been in practice 34 years. He specializes in pediatric kidney stone nephrology. He has more than 350 publications and over 2000 citings.
Education & Training
- Yale-New Haven Medical CenterFellowship, Pediatric Nephrology, 1991 - 1993
- Stony Brook Medicine/University HospitalResidency, Pediatrics, 1986 - 1989
- L. Tilak Municipal Medical CollegeClass of 1983
Certifications & Licensure
- OH State Medical License 2003 - 2027
- KY State Medical License 2021 - 2026
- IN State Medical License 2021 - 2021
- CT State Medical License 1993 - 1999
- American Board of Pediatrics Pediatric Nephrology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Prospective Research Rare Kidney Stones (ProRKS) Start of enrollment: 2016 May 01
Roles: Contact
Publications & Presentations
PubMed
- Alkaline urine is associated with increased risk of calcium phosphate nephrolithiasis in medically complex children receiving enteral nutrition.Edward Nehus, Marion Schulte, Prasad Devarajan, William DeFoor
Journal of Pediatric Urology. 2025-01-11 - Gucy1α1 specifically marks kidney, heart, lung and liver fibroblasts.Valeria Rudman-Melnick, Davy Vanhoutte, Kaitlynn Stowers, Michelle Sargent, Mike Adam
Scientific Reports. 2024-11-26 - Gucy1α1 specifically marks kidney, heart, lung and liver fibroblasts.Valeria Rudman-Melnick, Davy Vanhoutte, Kaitlynn Stowers, Michelle Sargent, Mike Adam
Research Square. 2024-08-17
Journal Articles
- Discovery of SERPINA3 as a Candidate Urinary Biomarker of Lupus Nephritis ActivityMichael Bennett, Hermine I Brunner, Prasad Devarajan, Gaurav Gulati, Jessica L Turnier, Sherry Thornton, David Witte, Bruce Aronow, Rheumatology
Abstracts/Posters
- Progression of Albuminuria in Sickle Cell Anemia: A Multicenter, Longitudinal StudyPrasad Devarajan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Section on Cardiology and Cardiac Surgery Program: Day 2National Conference & Exhibition 2019 - American Academy of Pediatrics - New Orleans, LA - 10/26/2019
Other
- Acute kidney injury in children: Clinical features, etiology, evaluation, and diagnosisDevarajan P
http://www.uptodate.com/contents/acute-kidney-injury-in-children-clinical-features-etiology-evaluati
UpToDate, Wolters Kluwer Health - 2013-04-01 - Prevention and management of acute kidney injury (acute renal failure) in childrenDevarajan P
http://www.uptodate.com/contents/prevention-and-management-of-acute-kidney-injury-acute-renal-failur
UpToDate, Wolters Kluwer Health - 2012-05-24
Press Mentions
- Gucy1α1 Acts as Fibrosis Biomarker in Multiple OrgansJanuary 30th, 2025
- BioPorto Is Proud to Have Nine of the Top-Ten Best US Children’s Hospitals as Customers of NGALOctober 22nd, 2024
- Preliminary Data Suggests Potential Use Beyond Early AKI Diagnosis for NGAL BiomarkerJuly 17th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: